Literature DB >> 18690639

Protease-triggered unveiling of bioactive nanoparticles.

Todd J Harris1, Geoffrey von Maltzahn, Matthew E Lord, Ji-Ho Park, Amit Agrawal, Dal-Hee Min, Michael J Sailor, Sangeeta N Bhatia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18690639      PMCID： PMC2759667          DOI： 10.1002/smll.200701319

Source DB:  PubMed          Journal:  Small        ISSN： 1613-6810            Impact factor:   13.281


× No keyword cloud information.
  27 in total

Review 1.  Drug-polymer conjugates containing acid-cleavable bonds.

Authors:  F Kratz; U Beyer; M T Schütte
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1999       Impact factor: 4.889

2.  Characterization of a novel pH-sensitive peptide that enhances drug release from folate-targeted liposomes at endosomal pHs.

Authors:  Mary Jo Turk; Joseph A Reddy; Jean A Chmielewski; Philip S Low
Journal:  Biochim Biophys Acta       Date:  2002-02-10

Review 3.  Long-circulating and target-specific nanoparticles: theory to practice.

Authors:  S M Moghimi; A C Hunter; J C Murray
Journal:  Pharmacol Rev       Date:  2001-06       Impact factor: 25.468

4.  In vivo molecular target assessment of matrix metalloproteinase inhibition.

Authors:  C Bremer; C H Tung; R Weissleder
Journal:  Nat Med       Date:  2001-06       Impact factor: 53.440

5.  Steric stabilization of fusogenic liposomes by a low-pH sensitive PEG--diortho ester--lipid conjugate.

Authors:  X Guo; F C Szoka
Journal:  Bioconjug Chem       Date:  2001 Mar-Apr       Impact factor: 4.774

6.  Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model.

Authors:  J Fang; Y Shing; D Wiederschain; L Yan; C Butterfield; G Jackson; J Harper; G Tamvakopoulos; M A Moses
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

7.  Serum-stable and long-circulating, PEGylated, pH-sensitive liposomes.

Authors:  Emmanuelle Roux; Catherine Passirani; Stefanie Scheffold; Jean-Pierre Benoit; Jean-Christophe Leroux
Journal:  J Control Release       Date:  2004-02-10       Impact factor: 9.776

Review 8.  Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates.

Authors:  Alberto Gabizon; Hilary Shmeeda; Aviva T Horowitz; Samuel Zalipsky
Journal:  Adv Drug Deliv Rev       Date:  2004-04-29       Impact factor: 15.470

Review 9.  On the formulation of pH-sensitive liposomes with long circulation times.

Authors:  Sérgio Simões; João Nuno Moreira; Cristina Fonseca; Nejat Düzgüneş; Maria C Pedroso de Lima
Journal:  Adv Drug Deliv Rev       Date:  2004-04-23       Impact factor: 15.470

10.  Pharmaco attributes of dioleoylphosphatidylethanolamine/cholesterylhemisuccinate liposomes containing different types of cleavable lipopolymers.

Authors:  Janny X Zhang; Samuel Zalipsky; Nasreen Mullah; Michal Pechar; Theresa M Allen
Journal:  Pharmacol Res       Date:  2004-02       Impact factor: 7.658
View more
  40 in total

1.  Layer-by-layer nanoparticles with a pH-sheddable layer for in vivo targeting of tumor hypoxia.

Authors:  Zhiyong Poon; Dongsook Chang; Xiaoyong Zhao; Paula T Hammond
Journal:  ACS Nano       Date:  2011-04-29       Impact factor: 15.881

Review 2.  Peptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates.

Authors:  Xiao-Xiang Zhang; Henry S Eden; Xiaoyuan Chen
Journal:  J Control Release       Date:  2011-10-26       Impact factor: 9.776

Review 3.  Growth factor delivery-based tissue engineering: general approaches and a review of recent developments.

Authors:  Kangwon Lee; Eduardo A Silva; David J Mooney
Journal:  J R Soc Interface       Date:  2010-08-18       Impact factor: 4.118

Review 4.  Emerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques.

Authors:  Shann S Yu; Ryan A Ortega; Brendan W Reagan; John A McPherson; Hak-Joon Sung; Todd D Giorgio
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2011-08-10

Review 5.  Smart nanosystems: Bio-inspired technologies that interact with the host environment.

Authors:  Ester J Kwon; Justin H Lo; Sangeeta N Bhatia
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-23       Impact factor: 11.205

Review 6.  Recent advances in nanobiotechnology and high-throughput molecular techniques for systems biomedicine.

Authors:  Eung-Sam Kim; Eun Hyun Ahn; Euiheon Chung; Deok-Ho Kim
Journal:  Mol Cells       Date:  2013-11-20       Impact factor: 5.034

Review 7.  Stimuli-responsive nanocarriers for drug delivery.

Authors:  Simona Mura; Julien Nicolas; Patrick Couvreur
Journal:  Nat Mater       Date:  2013-11       Impact factor: 43.841

8.  Clinical Cancer Nanomedicine.

Authors:  Joy Wolfram; Mauro Ferrari
Journal:  Nano Today       Date:  2019-03-06       Impact factor: 20.722

Review 9.  Strategies for improving drug delivery: nanocarriers and microenvironmental priming.

Authors:  Ayesha Khalid; Stefano Persano; Haifa Shen; Yuliang Zhao; Elvin Blanco; Mauro Ferrari; Joy Wolfram
Journal:  Expert Opin Drug Deliv       Date:  2016-10-11       Impact factor: 6.648

Review 10.  Targeting of drugs and nanoparticles to tumors.

Authors:  Erkki Ruoslahti; Sangeeta N Bhatia; Michael J Sailor
Journal:  J Cell Biol       Date:  2010-03-15       Impact factor: 10.539
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.